| 000 | 01728cam a2200157 4500 | ||
|---|---|---|---|
| 100 | 1 | _aDIEULIIS Diane | |
| 700 | _aGIORDANO James | ||
| 245 |
_aBalancing act: _bprecision medicine and national security/ _cDiane DiEuliis and James Giordano |
||
| 260 | _c2022 | ||
| 520 | _aDevelopments in genetics, pharmacology, biomarker identification, imaging, and interventional biotechnology are enabling medicine to become increasingly more precise in "personalized" approaches to assessing and treating individual patients. Here we describe current scientific and technological developments in precision medicine and elucidate the dual-use risks of employing these tools and capabilities to exert disruptive influence upon human health, economics, social structure, military capabilities, and global dimensions of power. We advocate continued enterprise toward more completely addressing nuances in the ethical systems and approaches that can-and should-be implemented (and communicated) to more effectively inform policy to guide and govern the biosecurity and use of current and emerging bioscience and technology on the rapidly shifting global stage. | ||
| 650 |
_aETHICS _xBIOLOGICAL MARKERS _xBIOTECHNOLOGY _xMEDICAL ECONOMICS _xMILITARY PERSONNEL _xDIAGNOSTIC IMAGING _xGENETICS _xPHARMACOLOGY _xSOCIAL STRUCTURE _xPRECISION MEDICINE _xMILITARY MEDICINE _xNATIONAL SECURITY _xPRECISION MEDICINE SUPPLEMENT |
||
| 773 |
_aMilitary Medicine: _gInternational Journal of AMSUS : Vol 187 Issue Supplement 1, January/February 2022, pp.32-35 (72) |
||
| 598 | _aMILITARY, HEALTH, NATSEC, ECONOMICS, POLICY, SOCIAL | ||
| 856 |
_uhttps://academic.oup.com/milmed/article/187/Supplement_1/32/6489948 _zClick here for full text |
||
| 945 |
_i67174.1001 _rY _sY |
||
| 999 |
_c41249 _d41249 |
||